Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (321-330 of 334) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>-Internal Tandem Duplication Mutation (SORMAIN)Andreas Burchert, Gesine Bug, Lea V Fritz, et al.
Nature Communications|January 10, 2024
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host diseaseKristina Maas-Bauer, Anna-Verena Stell, Kai-Li Yan, et al.
Blood|July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulationJenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Science Translational Medicine|February 23, 2018
Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsAlessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell TransplantationKatharina Fleischhauer, Cristina Toffalori, Federica Cugnata, et al.
Nature Immunology|March 26, 2026
A transcriptomic microglia taxonomy across mouse and human pathologiesChintan Chhatbar, Roman Sankowski, Michael Schulz, et al.
Blood|August 24, 2016
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHDRaphael Carapito, Nicolas Jung, Marius Kwemou, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Pageof 34

Showing results (321-330 of 334) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>-Internal Tandem Duplication Mutation (SORMAIN)Andreas Burchert, Gesine Bug, Lea V Fritz, et al.
Nature Communications|January 10, 2024
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host diseaseKristina Maas-Bauer, Anna-Verena Stell, Kai-Li Yan, et al.
Blood|July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulationJenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.
Blood|October 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AMLViktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, et al.
Science Translational Medicine|February 23, 2018
Oncogenic JAK2<sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasmsAlessandro Prestipino, Alica J Emhardt, Konrad Aumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell TransplantationKatharina Fleischhauer, Cristina Toffalori, Federica Cugnata, et al.
Nature Immunology|March 26, 2026
A transcriptomic microglia taxonomy across mouse and human pathologiesChintan Chhatbar, Roman Sankowski, Michael Schulz, et al.
Blood|August 24, 2016
Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHDRaphael Carapito, Nicolas Jung, Marius Kwemou, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Pageof 34